Skip to content
Search
By  Tedd Alexander, David Corris, CFA, Brian Dausch, CFA
Download the PDF

Why the stock market could broaden sustainably beyond U.S. large-cap growth

The AI arms race could contribute to a sustainable broadening in the equity markets.

January 2026, From the Field

Key Insights
  • The AI arms race is making the asset‑light U.S. mega caps more capital intensive. Their earnings growth also appears to be converging with other parts of the market.
  • Relative valuations, likely U.S. monetary policy, and the evolution of the AI trade could favor a broader swath of companies.
  • We favor diversified exposure to the broadening theme while maintaining respect for the potential durability of U.S. large‑cap growth leadership.

Stocks rose in the fourth quarter, driven by strong earnings, continued optimism around artificial intelligence (AI), and expectations for interest rate cuts—some of which the Federal Reserve delivered in October and December. Valuation mattered in most parts of the market. However, riskier value stocks tended to lead the way, as opposed to high‑quality or profitable value (Figure 1).

Quarterly factor returns

(Fig. 1) October 1, 2025–December 31, 2025
Quarterly factor returns

Past performance is not a guarantee or a reliable indicator of future results. Sources: Refinitiv/IDC data, Compustat, Worldscope, Russell, and MSCI. Analysis by T. Rowe Price. See Additional Disclosures for more detail on the sources used throughout this material. Total return data are in U.S. dollars. Factor returns are calculated as equal‑weighted quintile spreads.

Factors or factor analysis involves targeting quantifiable firm characteristics, or “factors,” that can explain differences in stock returns. Over the last 50 years, academic research has identified hundreds of factors that impact stock returns. See Appendix for calculation methodology, definitions of financial terms, and more details on the factors referenced throughout the article. The data presented in this material are for illustrative purposes only and do not represent an actual investment nor any T. Rowe Price product.

Key factor performance takeaways from Q4

Many clients have asked us whether and when equity markets will sustainably broaden beyond U.S. large‑cap growth stocks. Three interlinked themes from the fourth quarter are all relevant to this question.

  1. Global equity markets showed signs of broadening. Europe, Japan, and emerging markets outperformed U.S. large‑cap growth stocks in the fourth quarter. Within the U.S., large‑cap value and the small‑ and mid‑cap segment also outperformed large‑cap growth.
  2. The market’s risk appetite oscillated in the fourth quarter. Risk sentiment was strong for much of October before giving way to a run‑up in quality stocks that trailed off later in November. December brought another risk‑on rally as markets responded positively to the Fed’s rate cut (Figure 2). To us, this feels like a market in transition, with investors weighing whether to rotate from risk to quality.
  3. Debate around AI capital expenditures (capex) is a key driver. Prominent large‑cap growth companies have been spending unprecedented amounts of capital in the pursuit of AI leadership. Questions about where we are in the AI cycle and whether this spending will add value or prove destructive have fed into the market’s recent broadening and gyrations between risk‑on and risk‑off sentiment.

Returns for risk and quality factors oscillated in Q4

(Fig. 2) September 30, 2025, to December 31, 2025
Returns for risk and quality factors oscillated in Q4

Past performance is not a guarantee or a reliable indicator of future results.
Sources: Refinitiv/IDC data, Compustat, and FTSE/Russell. Analysis by T. Rowe Price. Total return data are in U.S. dollars. Factor returns are
calculated as equal‑weighted quintile spreads.  

A four‑part framework for further broadening in equity markets

Extreme market concentration and the continued leadership of U.S. large‑cap growth stocks have posed significant challenges for investors in recent years.

We believe the balance of evidence—key fundamental trends, the valuation setup, and potential second‑order drivers—suggests a higher probability of continued market broadening.

  • AI capex: Large‑cap growth companies are spending unprecedented amounts in pursuit of AI leadership. The outside view suggests that these outsized outlays could be negative for future returns.
  • Earnings growth convergence: A handful of mega‑cap companies have accounted for a significant proportion of annual earnings increases in the U.S. large‑cap growth segment. Consensus estimates indicate that these behemoths are still expected to grow their earnings meaningfully, but other market segments are increasingly catching up.
  • Valuation setup: Relative valuations are generally weak predictors of near‑term asset class performance. However, they do provide an outside view on what is priced in to markets. Current valuations suggest a higher bar for U.S. large‑cap growth stocks than other domestic and international market segments.
  • Second‑order trends: Expectations that the Fed will continue to lower interest rates in 2026 should be a catalyst for market broadening. Also, we believe the AI trade will shift from component suppliers to AI adopters, many of which reside in other parts of the market.

Although we consider further market broadening the most likely outcome, we are humble that it has been, and will continue to be, difficult to bet against U.S. large‑cap growth leadership. The high‑quality companies that dominate this market segment still benefit from exceptional competitive advantages, economies of scale, and winner‑take‑most dynamics in many of the verticals in which they operate.

1. The outside view on capex

One fundamental driver of U.S. large‑cap growth leadership has been the rise of asset‑light business models. But capital intensity is increasing, especially for the mega caps that dominate the U.S. large‑cap growth universe. As an example, consensus estimates suggest that aggregate capex for the “Magnificent Seven”—Alphabet, Amazon.com, Apple, Meta Platforms, Microsoft, NVIDIA, and Tesla—is expected to exceed USD 500 billion in 2026.

A key question is whether all this spending will be rewarded.

We can’t say with certainty what will happen this time, but we can share the outside view. History shows that companies with the highest capex are more likely to subsequently underperform (Figure 3), often for one or more reasons:

  • Poor timing: Firms often overextrapolate strong conditions and increase capex late in the cycle, just as returns on new projects begin to decline. This pattern has occurred across industries, from cyclical businesses such as shipbuilding to the post‑pandemic overordering that occurred in many areas, including consumer durables.
  • Declining marginal returns: As companies increase capex, subsequent projects naturally have lower expected returns, increasing the risk that the return on investment could come in below the cost of capital.
  • Behavioral biases: Firms often overinvest when cash flows are abundant, driven by incentives to deploy capital rather than return it to shareholders. Management tendencies toward empire building are another behavior that can lead to suboptimal returns on capital.

Firms with the highest capex to sales have tended to underperform

(Fig. 3) Historical returns for capex‑to‑sales quintiles in the Russell 1000 Index
Firms with the highest capex to sales have tended to underperform

Past performance is not a guarantee or a reliable indicator of future results. January 1, 1995, to December 31, 2025
Sources: Refinitiv/IDC data, Compustat, and Russell. Analysis by T. Rowe Price. Quintiles are constructed based on capex to sales, are equally weighted, are rebalanced monthly, and omit financials, utilities, and real estate investment trusts because capex and sales metrics may differ in these sectors. The underlying 12‑month total returns are in U.S. dollars and calculated on a rolling monthly basis. Each bar represents the average 12‑month return versus the Russell 1000 Index.

This outside view on historical capex cycles appears increasingly relevant as the mega caps plow money into AI infrastructure. These companies have experienced a prolonged positive business cycle with very high returns on equity and cash flow generation, so on the surface, the pattern seems to fit.

The circumstances of the AI capex cycle also call to mind another outside view: the “prisoner’s dilemma” from game theory. According to this framework, competitive pressures make maximum spending the dominant strategy, even if the companies driving AI investment would collectively benefit from restraint as the technology and use cases evolve. If this analogy holds, industrywide AI capex may be suboptimal and yield disappointing returns. Such a scenario is cautionary for large‑cap growth’s relative performance in the future.

That said, we acknowledge that the inside view—the specifics of the current situation—may be different due to the revolutionary nature of AI and the importance of not being left behind.

It’s also important to remember that capex has a different impact on the recipients than the spenders. The huge amounts of capital going to the AI buildout may also support market broadening because many of the capex beneficiaries will come from other market segments—small‑ to mid‑cap growth, for example. In that sense, the AI capex boom may serve dual purposes that both point to market broadening.

2. Earnings growth convergence

One fundamental reason for continued U.S. large‑cap growth leadership has been the group’s strong earnings growth relative to the rest of the market.

However, that advantage has eroded in recent quarters. In late 2025, the earnings growth rate for the small‑ to mid‑cap Russell 2500 Index had come closer to the Magnificent Seven.

Magnificent Seven’s collective growth advantage expected to narrow

(Fig. 4) Year‑over‑year (YoY) earnings growth
Magnificent Sevens collective growth advantage expected to narrow

As of January 12, 2026.
Sources: I/B/E/S, S&P, and FTSE/Russell. Analysis by T. Rowe Price. I/B/E/S © 2026 Refinitiv. All rights reserved. Annual earnings growth for past quarters reflects actual results; future quarters reflect consensus estimates. Actual outcomes may different materially from estimates. Does not represent data of any specific company. Not a recommendation to buy or sell any specific security.

Time will tell whether this convergence in earnings growth will prove durable. But current consensus estimates call for small and mid caps to grow at a similar pace to the Magnificent Seven and for the difference relative to the rest of the S&P 500 Index to narrow (Figure 4). We remain confident in U.S. large‑cap growth business quality, but this would call into question relative valuations.

3. Starting valuations provide a favorable setup

Relative valuations are weak short‑term predictors of stock performance, and they struggle to capture differences in growth and profitability. Nevertheless, they are useful in assessing what expectations are embedded in stock prices.

Forward price‑to‑earnings multiples for the Russell 1000 Growth Index remain elevated relative to the broader U.S. large‑cap market, U.S. small to mid caps, and global equities—a valuation gap that has persisted for the last five years (Figure 5).

Other market segments look cheap vs. U.S. large‑cap growth

(Fig. 5) 12‑month forward price‑to‑earnings ratio
Other market segments look cheap vs. U.S. large‑cap growth

December 31, 1994, to December 31, 2025
Sources: Refinitiv/IDC data, FTSE/Russell, and MSCI. Analysis by T. Rowe Price. I/B/E/S © 2026 Refinitiv. All rights reserved.

This dynamic could be akin to a coiled spring. If the returns from U.S. large‑cap growth capex disappoint and/or the group’s earnings growth converges with other parts of the market, there is plenty of potential energy for relative returns to broaden.

4. Second‑order trends that support market broadening

First, market consensus anticipates that the Fed is likely to continue lowering short‑term interest rates this year. This scenario could contribute to market breadth in two ways:

  • Smaller companies have more floating‑rate debt, so U.S. small‑ to mid‑cap stocks should benefit disproportionately from lower rates.
  • As money market rates become less attractive, some capital may rotate to dividend‑paying stocks, a dynamic that historically has favored U.S. large‑cap value and international markets.

Second, we believe the focus of the AI trade will shift at some point from the companies supplying the buildout to the adopters that can increase growth or improve margins by enhancing their operating models and leveraging proprietary data. Potential beneficiaries include banks, insurance companies, and cyclical industrials. Many of these companies are found outside the large‑cap growth universe.

Where could we be wrong?

The biggest risk to a call for further market broadening is familiar.

It has been a mistake to bet against the U.S. mega‑cap growth behemoths over the past decade, and many of their competitive advantages appear to remain in place. These companies historically have had attractive margins, earnings, and free cash flow. They have also benefited from winner‑take‑most dynamics and economies of scale.

Nevertheless, we believe the body of evidence suggests a higher probability of market broadening.

Conclusion

Many clients have asked about market concentration in U.S. large‑cap growth and whether the market can sustainably broaden.

We think the ingredients are falling into place for market breadth to improve.

From a fundamental perspective, the two most important drivers are the large‑cap growth capex cycle, which risks denting asset‑light business models, and expectations for this segment’s earnings growth rate to converge with other parts of the market. We also believe that starting valuations, likely monetary policy, and the evolution of the AI trade could benefit a broader swath of companies.

But we are humble that broadening means betting against some of the highest‑quality companies in the world. In our view, broadening is no longer a contrarian thesis—it is a conditional one, dependent on the returns from this capex cycle and earnings convergence.

Accordingly, we favor diversified exposure to the broadening theme while maintaining respect for the durability of U.S. large-cap growth leadership. We think this creates an attractive opportunity for U.S. large‑cap value, U.S. small‑ and mid‑cap stocks, and international asset classes.

 

Appendix

Factors are our internally constructed metrics, defined as follows:

Valuation: Proprietary composite of valuation metrics based on earnings, sales, book value, and dividends. Specific value factor weighting may vary by region and sector.

Growth: Proprietary composite of growth metrics based on historical and forward‑looking earnings and sales growth. Factor selection and weighting vary by region and industry.

Momentum: Proprietary measure of medium‑term price momentum.

Quality: Proprietary measure of quality based on fundamental and stock price stability; balance sheet strength; and measures of profitability, capital usage, and earnings quality.

Profitability: Return on equity.

Risk: In this paper, risk is the standard deviation of trailing 12‑month returns. High‑risk stocks exhibit higher standard deviations, indicating a wider degree of variation or dispersion in their historical return.

Size: Market capitalization (positive return means larger stocks outperform smaller stocks).

Quintile spread: Also referred to as long‑short returns, a quintile spread is calculated by sorting securities based on a specific characteristic or factor criterion, dividing them into five groups (or quintiles), equal‑weighting the securities within each quintile, and then subtracting the bottom‑quintile returns (lowest 20%) from the top‑quintile returns (highest 20%).

Factors and indices cannot be invested in directly and are shown for illustrative purposes only. They do not reflect performance of actual investments nor do they reflect the reduction of fees associated with an actual investment, such as trading costs and management fees.

For definitions of certain financial terms, visit https://www.troweprice.com/en/us/glossary.

All investments are subject to market risk, including the possible loss of principal. Past favorable company characteristics may not persist into the future. Diversification cannot assure a profit or protect against loss in declining markets.

Risks: Growth stocks are subject to the volatility inherent in common stock investing, and their share price may fluctuate more than that of income‑oriented stocks. The value approach to investing carries the risk that the market will not recognize a security’s intrinsic value for a long time or that a stock judged to be undervalued may actually be appropriately priced. Small‑cap stocks have generally been more volatile in price than large‑cap stocks. Mid-caps generally have been more volatile than stocks of large, well-established companies. Investing in technology stocks entails specific risks, including the potential for wide variations in performance and usually wide price swings, up and down. Technology companies can be affected by, among other things, intense competition, government regulation, earnings disappointments, dependency on patent protection, and rapid obsolescence of products and services due to technological innovations or changing consumer preferences. International investments can be riskier than U.S. investments due to the adverse effects of currency exchange rates, differences in market structure and liquidity, as well as specific country, regional, and economic developments. Financial services companies may be hurt when interest rates rise sharply and may be vulnerable to rapidly rising inflation.

Tedd Alexander Head, Global Integrated Equity David Corris, CFA Portfolio Manager Brian Dausch, CFA Portfolio Specialist
Mar 2025 From the Field Article

In a world of flux, fundamentals (and active stock picking) matter

Durable, compound growth companies look best placed to navigate the near-term landscape.
By  Justin P. White, CFA
Mar 2025 From the Field Article

AI²: How radical innovations are revolutionizing tech and health care

Twin developments are transforming the investment landscape.

Additional Disclosures

For U.S. investors, visit troweprice.com/glossary for definitions of financial terms.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

© 2026 Refinitiv. All rights reserved.

MSCI and its affiliates and third party sources and providers (collectively, “MSCI”) makes no express or implied warranties or representations and shall have no liability whatsoever with respect to any MSCI data contained herein. The MSCI data may not be further redistributed or used as a basis for other indices or any securities or financial products. This report is not approved, reviewed, or produced by MSCI. Historical MSCI data and analysis should not be taken as an indication or guarantee of any future performance analysis, forecast or prediction. None of the MSCI data is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such.

London Stock Exchange Group plc and its group undertakings (collectively, the “LSE Group”). © LSE Group 2026. FTSE Russell is a trading name of certain of the LSE Group companies. Russell® is a trade mark of the relevant LSE Group companies and is/are used by any other LSE Group company under license. All rights in the FTSE Russell indexes or data vest in the relevant LSE Group company which owns the index or the data. Neither LSE Group nor its licensors accept any liability for any errors or omissions in the indexes or data and no party may rely on any indexes or data contained in this communication. No further distribution of data from the LSE Group is permitted without the relevant LSE Group company’s express written consent. The LSE Group does not promote, sponsor or endorse the content of this communication. The LSE Group is not responsible for the formatting or configuration of this material or for any inaccuracy in T. Rowe Price’s presentation thereof.

The S&P 500 is a product of S&P Dow Jones Indices LLC, a division of S&P Global, or its affiliates (“SPDJI”) and has been licensed for use by T. Rowe Price. Standard & Poor’s and S&P are registered trademarks of Standard & Poor’s Financial Services LLC, a division of S&P Global (“S&P”); Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC (“Dow Jones”). T. Rowe Price is not sponsored, endorsed, sold or promoted by SPDJI, Dow Jones, S&P, their respective affiliates, and none of such parties make any representation regarding the advisability of investing in such product(s) nor do they have any liability for any errors, omissions, or interruptions of the S&P 500.

Refinitiv, Compustat, FTSE/Russell, and MSCI do not accept any liability for any errors or omissions in the indexes or data, and hereby expressly disclaim all warranties of originality, accuracy, completeness, timeliness, merchantability and fitness for a particular purpose. No party may rely on any indexes or data contained in this communication. Visit https://www.troweprice.com/en/us/market‑data‑disclosures for additional legal notices & disclaimers.

Important Information

Outside of the United States, this is intended for investment professional use only. Not for further distribution.

This material is being furnished for informational and/or marketing purposes only and does not constitute an offer, recommendation, advice, or solicitation to sell or buy any security.

Prospective investors should seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services.

Past performance is not a guarantee or a reliable indicator of future results. All investments involve risk, including possible loss of principal.

Information presented has been obtained from sources believed to be reliable, however, we cannot guarantee the accuracy or completeness. The views contained herein are those of the author(s), are as of January 2026, are subject to change, and may differ from the views of other T. Rowe Price Group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.

All charts and tables are shown for illustrative purposes only. Actual future outcomes may differ materially from any estimates or forward‑looking statements provided.

The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request.

Australia—Issued by T. Rowe Price Australia Limited (ABN: 13 620 668 895 and AFSL: 503741), Level 28, Governor Phillip Tower, 1 Farrer Place, Sydney NSW 2000, Australia. For Wholesale Clients only. 

Canada—Issued in Canada by T. Rowe Price (Canada), Inc. T. Rowe Price (Canada), Inc.’s investment management services are only available to non‑individual Accredited Investors and non‑individual Permitted Clients as defined under National Instrument 45‑106 and National Instrument 31‑103, respectively. T. Rowe Price (Canada), Inc. enters into written delegation agreements with affiliates to provide investment management services. 

EEA—Unless indicated otherwise this material is issued and approved by T. Rowe Price (Luxembourg) Management S.à r.l. 35 Boulevard du Prince Henri L‑1724 Luxembourg which is authorised and regulated by the Luxembourg Commission de Surveillance du Secteur Financier. For Professional Clients only. 

New Zealand—Issued by T. Rowe Price Australia Limited (ABN: 13 620 668 895 and AFSL: 503741), Level 28, Governor Phillip Tower, 1 Farrer Place, Sydney NSW 2000, Australia. No Interests are offered to the public. Accordingly, the Interests may not, directly or indirectly, be offered, sold or delivered in New Zealand, nor may any offering document or advertisement in relation to any offer of the Interests be distributed in New Zealand, other than in circumstances where there is no contravention of the Financial Markets Conduct Act 2013. 

Switzerland—Issued in Switzerland by T. Rowe Price (Switzerland) GmbH, Talstrasse 65, 6th Floor, 8001 Zurich, Switzerland. For Qualified Investors only. 

UK—This material is issued and approved by T. Rowe Price International Ltd, Warwick Court, 5 Paternoster Square, London EC4M 7DX which is authorised and regulated by the UK Financial Conduct Authority. For Professional Clients only. 

USA—Issued in the USA by T. Rowe Price Investment Services, Inc., distributor and T. Rowe Price Associates, Inc., investment adviser, 1307 Point Street, Baltimore, MD 21231, which are regulated by the Financial Industry Regulatory Authority and the U.S. Securities and Exchange Commission, respectively.

© 2026 T. Rowe Price. All Rights Reserved. T. Rowe Price, INVEST WITH CONFIDENCE, the Bighorn Sheep design, and related indicators (see troweprice.com/ip) are trademarks of T. Rowe Price Group, Inc. All other trademarks are the property of their respective owners. Use does not imply endorsement, sponsorship, or affiliation of T. Rowe Price with any of the trademark owners.

202601‑5108927

Open

Audience for the document: Share Class: Language of the document:
Open Cancel

Open

Share Class: Language of the document:
Open Cancel
Sign in to manage subscriptions for products, insights and email updates.
Sign in
Once registered, you'll be able to start subscribing.

Change Details

If you need to change your email address please contact us.
Subscriptions
OK
You are ready to start subscribing.
Get started by going to our products or insights section to follow what you're interested in.

Products Insights

GIPS® Information

T. Rowe Price (“TRP”) claims compliance with the Global Investment Performance Standards (GIPS®).

A complete list and description of the Firm's composites and/or a presentation that adheres to the GIPS® standards are available upon request. Additional information regarding the firm's policies and procedures for calculating and reporting performance results is available upon request

Other Literature

You have successfully subscribed.

Notify me by email when
regular data and commentary is available
exceptional commentary is available
new articles become available

Thank you for your continued interest